Skip to main content

Table 3 Morphologic Distribution and Frequency of most common cancers in East Azerbaijan Province in 2015-2016

From: Cancer incidence in the East Azerbaijan province of Iran in 2015–2016: results of a population-based cancer registry

Cancer Site   Frequent Percent Cancer Site   Frequent Percent Cancer Site   Frequent Percent
Cardiac Gastric Cancer Gender    Esophageal Cancer Gender    Breast Cancer Gender   
Neoplasm, Malignant Male 4 7.0 Neoplasm, Malignant Male 14 8.1 Neoplasm, Malignant Male 1 0.14
Female 2 8.0 Female 9 5.7 Female 43 6.09
Epithelial Tumor, Malignant Male 1 1.8 Epithelial Tumor, Malignant Male 4 2.3 Carcinoma Male - -
Female - - Female 2 1.3 Female 28 3.96
Squamous Cell Carcinoma Male 1 1.8 Squamous Cell carcinoma Male 131 75.7 Papillary Carcinoma Male 1 0.14
Female 8 32.0 Female 141 88.7 Female - -
Adenocarcinoma/NOS Male 24 42.1 Adenocarcinoma/NOS Male 9 5.2 Squamous Cell Carcinoma Male - -
Female 8 32.0 Female 5 3.1 Female 1 0.14
Adenocarcinoma, Intestinal Type Male 19 33.3 Adenocarcinoma, Intestinal Type Male 12 6.9 Adenocarcinoma Male - -
Female 4 16.0 Female 1 .6 Female 1 0.14
Adenocarcinoma, Diffuse Type Male 4 7.0 Adenocarcinoma, Diffuse Type Male - - Tubular Adenocarcinoma Male - -
Female 1 4.0 Female - - Female 1 0.14
Mucinous Adenocarcinoma Male 1 1.8 Mucinous Adenocarcinoma Male 1 .6 Mucinous Adenocarcinoma Male - -
Female - - Female - - Female 1 0.14
Sebaceous Adenocarcinoma Male - - Sebaceous Adenocarcinoma Male - - Signet Ring Cell Carcinoma Male - -
Female 1 4.0 Female - - Female 1 0.14
Signet Ring Cell Carcinoma Male 3 5.3 Signet Ring Cell Carcinoma Male 1 .6 Ductal Carcinoma Male 12 1.6
Female 1 4.0 Female - - Female 587 83.14
Others Male - - Others Male 1 .6 Medullary Carcinoma Male - -
  Female - - Female 1 .6 Female 8 1.13
Total Male 57 100.0 Total Male 173 100.0 Lobular Carcinoma Male - -
Female 25 100.0 Female 159 100.0 Female 17 2.40
Non-Cardiac Gastric Cancer     Colorectal Cancer     Infiltrating Ductal and Lobular Carcinoma Male - -
Neoplasm, Malignant Male 55 9.9 Neoplasm, Malignant Male 20 5.4 Female 1 0.14
Female 31 11.1 Female 33 10.7 Phylloides Tumor Malignant Male - -
Epithelial Tumor, Malignant Male 7 1.3 Epithelial Tumor, Malignant Male 1 .3 Female 2 0.28
Female 6 2.1 Female - - Myeloid Sarcoma Male - -
Squamous Cell Carcinoma Male 3 .5 Squamous Cell Carcinoma Male 2 .5 Female 1 0.14
Female 1 .4 Female 2 .7 Unknown Male - -
Adenocarcinoma/NOS Male 281 50.4 Adenocarcinoma/NOS Male 330 89.9 Female - -
Female 147 52.5 Female 254 82.7 Total Male 14 100.0
Adenocarcinoma, Intestinal Type Male 155 27.8 Adenocarcinoma, Intestinal Type Male - - Female 692 100.0
Female 71 25.4 Female 1 .3 Lung Cancer    
Adenocarcinoma, Diffuse Type Male 18 3.2 Adenocarcinoma, Diffuse Type Male - - Neoplasm, Malignant Male 88 19.86
Female 6 2.1 Female 1 .3 Female 40 9.02
Mucinous Adenocarcinoma Male 4 .7 Mucinous Adenocarcinoma Male 6 1.6 Malignant Tumor, Small Cell Type Male 2 0.45
Female 1 .4 Female 3 1.0 Female - -
Sebaceous Adenocarcinoma Male - - Sebaceous Adenocarcinoma Male - - Malignant Tumor, Spindle Cell Type Male - -
Female - - Female - - Female 1 0.22
Signet Ring Cell Carcinoma Male 26 4.7 Signet Ring Cell Carcinoma Male 4 1.1 Carcinoma Male 11 2.48
Female 13 4.6 Female 4 1.3 Female 5 1.12
Others Male 2 .4 Others Male 4 1.2 Small Cell Carcinoma, NOS Male 12 2.70
Female 3 1.1 Female 6 1.8 Female 3 0.67
Unknown Male 6 1.1 Unknown Male - - Non-small Cell Carcinoma Male 5 1.12
Female 1 .4 Female - - Female 1 0.22
Total Male 551 100.0 Total Male 367 100.0 Squamous Cell Carcinoma Male 172 38.81
Female 279 100.0 Female 307 100.0 Female 54 12.18
Thyroid Cancer     Prostate     Adenocarcinoma Male 27 6.09
Neoplasm, Malignant Male 4 1.70 Neoplasm, Malignant Male 19 5.09 Female 9 2.03
Female 8 3.40 Female - - Carcinoid Tumor, NOS Male - -
Papillary Carcinoma Male 9 3.82 Carcinoma Male 78 20.91 Female 4 0.90
Female 28 11.91 Female - - Bronchiolo-Alveolar Adenocarcinoma, NOS Male 3 0.67
Squamous Cell Carcinoma Male - - Carcinoma, Undifferentiated ,NOS Male 1 0.26 Female - -
Female 1 0.42 Female - - Signet Ring Cell Carcinoma, Male 1 0.22
Papillary Adenocarcinoma Male 41 17.44 Squamous Cell Carcinoma Male 1 0.26 Female - -
Female 101 42.97 Female - - Sarcoma, NOS Male - -
Oxyphilic Adenocarcinoma Male 1 0.42 Transitional Cell Carcinoma, NOS Male 3 0.80 Female 1 0.22
Female 6 2.55 Female - - Spindle cell Sarcoma Male 1 0.22
Follicular Adenocarcinoma Male 2 0.85 Papillary Transitional Cell Carcinoma Male 3 0.80 Female - -
Female 13 5.52 Female - - Total Male 322 100.0
Insular Carcinoma Male - - Adenocarcinoma Male 266 71.31   Female 118 100.0
Female 1 0.42 Female - - Bladder Cancer Gender   
Papillary Carcinoma, Follicular Variant Male 3 1.27 Adenocarcinoma, Intestinal Type Male 2 0.53 Neoplasm, Malignant Male 17 3.82
Female 13 5.53 Female - - Female 2 0.44
Medullary Carcinoma with Amyloid Stroma Male 1 0.42 Unknown Male - - Transitional Cell Carcinoma, NOS Male 217 48.76
Female -   Female - - Female 49 11.01
Mixed Medullary Carcinoma Male 2 .84 Total Male 373 100.0 Papillary Carcinoma Male 1 0.22
Female -   Female - - Female 1 0.22
Medullary Carcinoma, NOS Male -       Squamous Cell Carcinoma Male 1 0.22
Female 3 1.27      Female - -
Total Male 62 100.0      Papillary Transitional Cell Carcinoma Male 117 26.29
Female 173 100.0      Female 34 7.64
         Adenocarcinoma Male 2 0.44
         Female 1 0.22
         Carcinoid tumor, NOS Male 3 0.66
         Female - -
         Total Male 358 100.0
         Female 87 100.0
\